Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1989 Dec;135(6):1145–1156.

Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.

H Ratech 1, R Hirschhorn 1, M A Greco 1
PMCID: PMC1880483  PMID: 2596574

Abstract

Eight autopsies of patients with adenosine deaminase deficient-severe combined immunodeficiency disease (ADA-SCID) were reviewed with special emphasis on the lymphoid tissues. The thymus histology in five cases was remarkably uniform, whether or not prior ADA enzyme replacement or immunologic reconstitution therapy had been administered. Lymph nodes and spleens in all cases examined showed a residual nonlymphoid architectural framework corresponding to usual T and B cell zones found in normals. The development of an extranodal, monoclonal IgA lambda B cell immunoblastic lymphoma as a terminal event in one patient after several years of successful ADA enzyme replacement therapy through multiple red blood cell transfusions is described. In another patient with long-term ADA enzyme replacement, a terminal autoimmune hemolytic anemia developed. Autopsy revealed severe deposits of iron in the B cell zones of the lymph nodes, which is an unusual location. In addition, iron deposits outlined the splenic trabeculae, as well as the ring fibers and bridging fibers of the splenic sinuses.

Full text

PDF
1145

Images in this article

1147Figure 1
on p.1147
1148Figure 2
on p.1148
1148Figure 3
on p.1148
1150Figure 4
on p.1150
1150Figure 5
on p.1150
1151Figure 6
on p.1151
1151Figure 7
on p.1151
1152Figure 8
on p.1152
1153Figure 9
on p.1153
1154Figure 10
on p.1154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackeret C., Llüss H. J., Hitzig W. H. Hereditary sever combined immunodeficiency and adenosine deaminase deficiency. Pediatr Res. 1976 Jan;10(1):67–70. doi: 10.1203/00006450-197601000-00013. [DOI] [PubMed] [Google Scholar]
  2. Al-Mondhiry H. Primary lymphomas of the small intestine: east-west contrast. Am J Hematol. 1986 May;22(1):89–105. doi: 10.1002/ajh.2830220114. [DOI] [PubMed] [Google Scholar]
  3. Borzy M. S., Hong R., Horowitz S. D., Gilbert E., Kaufman D., DeMendonca W., Oxelius V. A., Dictor M., Pachman L. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med. 1979 Sep 13;301(11):565–568. doi: 10.1056/NEJM197909133011101. [DOI] [PubMed] [Google Scholar]
  4. Borzy M. S., Schulte-Wissermann H., Gilbert E., Horowitz S. D., Pellett J., Hong R. Thymic morphology in immunodeficiency diseases: results of thymic biopsies. Clin Immunol Immunopathol. 1979 Jan;12(1):31–51. doi: 10.1016/0090-1229(79)90109-0. [DOI] [PubMed] [Google Scholar]
  5. Cederbaum S. D., Kaitila I., Rimoin D. L., Stiehm E. R. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr. 1976 Nov;89(5):737–742. doi: 10.1016/s0022-3476(76)80793-7. [DOI] [PubMed] [Google Scholar]
  6. Cleary M. L., Epstein M. A., Finerty S., Dorfman R. F., Bornkamm G. W., Kirkwood J. K., Morgan A. J., Sklar J. Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones. Science. 1985 May 10;228(4700):722–724. doi: 10.1126/science.2986287. [DOI] [PubMed] [Google Scholar]
  7. Dyminski J. W., Daoud A., Lampkin B. C., Limouze S., Donofrio J., Coleman M. S., Hutton J. J. Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease. Clin Immunol Immunopathol. 1979 Nov;14(3):307–326. doi: 10.1016/0090-1229(79)90157-0. [DOI] [PubMed] [Google Scholar]
  8. Forman S. J., Sullivan J. L., Wright C., Ratech H., Racklin B., Blume K. G. Epstein-Barr-virus-related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemia. Transplantation. 1987 Aug;44(2):244–249. doi: 10.1097/00007890-198708000-00014. [DOI] [PubMed] [Google Scholar]
  9. Frizzera G., Hanto D. W., Gajl-Peczalska K. J., Rosai J., McKenna R. W., Sibley R. K., Holahan K. P., Lindquist L. L. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981 Nov;41(11 Pt 1):4262–4279. [PubMed] [Google Scholar]
  10. Frizzera G., Rosai J., Dehner L. P., Spector B. D., Kersey J. H. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer. 1980 Aug 15;46(4):692–699. doi: 10.1002/1097-0142(19800815)46:4<692::aid-cncr2820460410>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Galian A., Lecestre M. J., Scotto J., Bognel C., Matuchansky C., Rambaud J. C. Pathological study of alpha-chain disease, with special emphasis on evolution. Cancer. 1977 May;39(5):2081–2101. doi: 10.1002/1097-0142(197705)39:5<2081::aid-cncr2820390526>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  12. Garcia C. R., Brown N. A., Schreck R., Stiehm E. R., Hudnall S. D. B-cell lymphoma in severe combined immunodeficiency not associated with the Epstein-Barr virus. Cancer. 1987 Dec 15;60(12):2941–2947. doi: 10.1002/1097-0142(19871215)60:12<2941::aid-cncr2820601216>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  13. Gatti R. A., Good R. A. Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer. 1971 Jul;28(1):89–98. doi: 10.1002/1097-0142(197107)28:1<89::aid-cncr2820280117>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  14. Gelfand E. W., Baumal R., Huber J., Crookston M. C., Shumak K. H. Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease. N Engl J Med. 1973 Dec 27;289(26):1385–1389. doi: 10.1056/NEJM197312272892602. [DOI] [PubMed] [Google Scholar]
  15. Gelfand E. W., Dosch H. M. Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects Orig Artic Ser. 1983;19(3):65–72. [PubMed] [Google Scholar]
  16. Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
  17. Gosseye S., Diebold N., Griscelli C., Nezelof C. Severe combined immunodeficiency disease: a pathological analysis of 26 cases. Clin Immunol Immunopathol. 1983 Oct;29(1):58–77. doi: 10.1016/0090-1229(83)90007-7. [DOI] [PubMed] [Google Scholar]
  18. Groshong T., Horowitz S., Lovchik J., Davis A., Hong R. Chronic cytomegalovirus infection, immunodeficiency, and monoclonal gammopathy-antigen-driven malignancy? J Pediatr. 1976 Feb;88(2):217–223. doi: 10.1016/s0022-3476(76)80985-7. [DOI] [PubMed] [Google Scholar]
  19. Hanto D. W., Frizzera G., Gajl-Peczalska K. J., Simmons R. L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 1985 May;39(5):461–472. doi: 10.1097/00007890-198505000-00001. [DOI] [PubMed] [Google Scholar]
  20. Harrington D. S., Weisenburger D. D., Purtilo D. T. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer. 1987 Apr 15;59(8):1419–1429. doi: 10.1002/1097-0142(19870415)59:8<1419::aid-cncr2820590807>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  21. Hirschhorn R., Paageorgiou P. S., Kesarwala H. H., Taft L. T. Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med. 1980 Aug 14;303(7):377–380. doi: 10.1056/NEJM198008143030706. [DOI] [PubMed] [Google Scholar]
  22. Hirschhorn R., Ratech H. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias. Curr Top Hematol. 1983;4:1–35. [PubMed] [Google Scholar]
  23. Hirschhorn R., Vawter G. F., Kirkpatrick J. A., Jr, Rosen F. S. Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency. Clin Immunol Immunopathol. 1979 Sep;14(1):107–120. doi: 10.1016/0090-1229(79)90131-4. [DOI] [PubMed] [Google Scholar]
  24. Hitzig W. H., Landolt R., Müller G., Bodmer P. Heterogeneity of phenotypic expression in a family with Swiss-type agammaglobulinemia: observations on the acquisition of agammaglobulinemia. J Pediatr. 1971 Jun;78(6):968–980. doi: 10.1016/s0022-3476(71)80426-2. [DOI] [PubMed] [Google Scholar]
  25. Huang T. W., Wiegenstein L. M. Mesangiolytic glomerulonephritis in an infant with immune deficiency and echovirus infection. Arch Pathol Lab Med. 1977 Mar;101(3):125–128. [PubMed] [Google Scholar]
  26. Isaacson P. G., Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987 May;11(5):445–462. doi: 10.1111/j.1365-2559.1987.tb02654.x. [DOI] [PubMed] [Google Scholar]
  27. Isaacson P., Wright D. H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984 Jun 1;53(11):2515–2524. doi: 10.1002/1097-0142(19840601)53:11<2515::aid-cncr2820531125>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  28. Isaacson P., Wright D. H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983 Oct 15;52(8):1410–1416. doi: 10.1002/1097-0142(19831015)52:8<1410::aid-cncr2820520813>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  29. Kapoor N., Jung L. K., Engelhard D., Filler J., Shalit I., Landreth K. S., Good R. A. Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow. J Pediatr. 1986 Mar;108(3):435–438. doi: 10.1016/s0022-3476(86)80892-7. [DOI] [PubMed] [Google Scholar]
  30. Kersey J. H., Spector B. D., Good R. A. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer. 1973 Sep 15;12(2):333–347. doi: 10.1002/ijc.2910120204. [DOI] [PubMed] [Google Scholar]
  31. King J. T., Puchtler H., Sweat F. Ring fibers in human spleens. Arch Pathol. 1968 Mar;85(3):237–245. [PubMed] [Google Scholar]
  32. Lichtenstein A., Levine A. M., Lukes R. J., Cramer A. D., Taylor C. R., Lincoln T. L., Feinstein D. I. Immunoblastic sarcoma: a clinical description. Cancer. 1979 Jan;43(1):343–352. doi: 10.1002/1097-0142(197901)43:1<343::aid-cncr2820430149>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  33. Linch D. C., Levinsky R. J., Rodeck C. H., Maclennan K. A., Simmonds H. A. Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency. Clin Exp Immunol. 1984 May;56(2):223–232. [PMC free article] [PubMed] [Google Scholar]
  34. Martin P. J., Shulman H. M., Schubach W. H., Hansen J. A., Fefer A., Miller G., Thomas E. D. Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann Intern Med. 1984 Sep;101(3):310–315. doi: 10.7326/0003-4819-101-3-310. [DOI] [PubMed] [Google Scholar]
  35. Matas A. J., Hertel B. F., Rosai J., Simmoms R. L., Najarian J. S. Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. Am J Med. 1976 Nov;61(5):716–720. doi: 10.1016/0002-9343(76)90151-0. [DOI] [PubMed] [Google Scholar]
  36. Meuwissen H. J., Pollara B., Pickering R. J. Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973. J Pediatr. 1975 Feb;86(2):169–181. doi: 10.1016/s0022-3476(75)80463-x. [DOI] [PubMed] [Google Scholar]
  37. Moore E. C., Laffin R. J., Tomasi T., Pickering R. J., Radl J., Meuwissen H. J. Regional deficiency of secretory IgA in a patient with combined immunodeficiency of the ADA deficient type. Acta Paediatr Scand. 1979 May;68(3):453–458. doi: 10.1111/j.1651-2227.1979.tb05038.x. [DOI] [PubMed] [Google Scholar]
  38. Peter H. H., Friedrich W., Dopfer R., Müller W., Kortmann C., Pichler W. J., Heinz F., Rieger C. H. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients. J Immunol. 1983 Nov;131(5):2332–2339. [PubMed] [Google Scholar]
  39. Ratech H., Bell M. K., Hirschhorn R., Thorbecke G. J. Effects of deoxycoformycin in mice. I. Suppression and enhancement of in vivo antibody responses to thymus-dependent and -independent antigens. J Immunol. 1984 Jun;132(6):3071–3076. [PubMed] [Google Scholar]
  40. Ratech H., Greco M. A., Gallo G., Rimoin D. L., Kamino H., Hirschhorn R. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations. Am J Pathol. 1985 Jul;120(1):157–169. [PMC free article] [PubMed] [Google Scholar]
  41. Ratech H., Thorbecke G. J., Hirschhorn R. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Clin Immunol Immunopathol. 1981 Oct;21(1):119–127. doi: 10.1016/0090-1229(81)90200-2. [DOI] [PubMed] [Google Scholar]
  42. Reece E. R., Gartner J. G., Seemayer T. A., Joncas J. H., Pagano J. S. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res. 1981 Nov;41(11 Pt 1):4243–4247. [PubMed] [Google Scholar]
  43. Rickinson A. B., Wallace L. E., Epstein M. A. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature. 1980 Feb 28;283(5750):865–867. doi: 10.1038/283865a0. [DOI] [PubMed] [Google Scholar]
  44. Saemundsen A. K., Purtilo D. T., Sakamoto K., Sullivan J. L., Synnerholm A. C., Hanto D., Simmons R., Anvret M., Collins R., Klein G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res. 1981 Nov;41(11 Pt 1):4237–4242. [PubMed] [Google Scholar]
  45. Shearer W. T., Ritz J., Finegold M. J., Guerra I. C., Rosenblatt H. M., Lewis D. E., Pollack M. S., Taber L. H., Sumaya C. V., Grumet F. C. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med. 1985 May 2;312(18):1151–1159. doi: 10.1056/NEJM198505023121804. [DOI] [PubMed] [Google Scholar]
  46. Shirley L. R., Buckley R. H., Borowitz M. J., Welt S. I., Kostyu D. D. Monoclonal immunoglobulin-secreting lymphoma in a patient with severe combined immunodeficiency disease. Clin Exp Immunol. 1982 Jun;48(3):666–674. [PMC free article] [PubMed] [Google Scholar]
  47. Smith W. J., Price S. K., Isaacson P. G. Immunoglobulin gene rearrangement in immunoproliferative small intestinal disease (IPSID). J Clin Pathol. 1987 Nov;40(11):1291–1297. doi: 10.1136/jcp.40.11.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Spector B. D., Perry G. S., 3rd, Kersey J. H. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry. Clin Immunol Immunopathol. 1978 Sep;11(1):12–29. doi: 10.1016/0090-1229(78)90200-3. [DOI] [PubMed] [Google Scholar]
  49. Wennberg E., Weiss L. The structure of the spleen and hemolysis. Annu Rev Med. 1969;20:29–40. doi: 10.1146/annurev.me.20.020169.000333. [DOI] [PubMed] [Google Scholar]
  50. Yount J., Nichols P., Ochs H. D., Hammar S. P., Scott C. R., Chen S. H., Giblett E. R., Wedgwood R. J. Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr. 1974 Feb;84(2):173–177. doi: 10.1016/s0022-3476(74)80597-4. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES